Checkpoint Trends Stock Hits All-Time High at Rs.105.32

Dec 03 2025 10:32 AM IST
share
Share Via
Checkpoint Trends, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.105.32 today, marking a significant milestone in its market journey. The stock’s sustained upward momentum reflects a remarkable performance over multiple time frames, outpacing broader market indices and sector peers.



Strong Price Momentum and Market Outperformance


On the day of this record peak, Checkpoint Trends recorded a gain of 1.99%, contrasting with the Sensex’s decline of 0.33%. This outperformance extends beyond a single session, with the stock outperforming its sector by 2.45% today. The stock opened at Rs.105.32 and maintained this level throughout the trading session, underscoring robust demand and price stability at this elevated level.


Checkpoint Trends has demonstrated a consistent upward trajectory, with gains recorded over the last 21 consecutive trading days. During this period, the stock delivered a total return of 51.34%, a notable achievement in comparison to the Sensex’s 1.05% return over the same one-month span. This sustained rally highlights the stock’s resilience and investor confidence in its underlying business fundamentals.



Long-Term Performance Highlights


Examining longer-term performance, Checkpoint Trends exhibits exceptional returns across multiple horizons. Over the past three months, the stock’s price appreciation stands at 206.52%, significantly outstripping the Sensex’s 5.33% gain. The one-year return is even more striking at 538.30%, compared to the Sensex’s 4.96% during the same period.


Year-to-date figures reveal a remarkable 707.05% return for Checkpoint Trends, dwarfing the Sensex’s 8.60%. Extending the view further, the stock’s three-year performance shows a gain of 2443.96%, while the five-year and ten-year returns reach 4601.79% and 7163.45% respectively. These figures illustrate a long-standing pattern of substantial value creation for shareholders, far exceeding the broader market’s corresponding returns of 34.98%, 90.13%, and 227.81% over the same periods.



Technical Indicators Confirm Uptrend


Technical analysis supports the stock’s strong position, with Checkpoint Trends trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment of short, medium, and long-term moving averages signals a sustained bullish trend and underlines the stock’s price strength.




Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.



  • - Strong fundamental track record

  • - Consistent growth trajectory

  • - Reliable price strength


Count on This Pick →




Sector Context and Market Capitalisation


Checkpoint Trends operates within the Pharmaceuticals & Biotechnology sector, a domain characterised by innovation and growth potential. The company’s market capitalisation grade is noted as 4, indicating a mid-sized market presence relative to its peers. This positioning allows the stock to benefit from both growth opportunities and increasing investor attention within the sector.


The stock’s recent performance contrasts with the broader sector and market indices, which have shown more modest gains. For instance, over the past week, Checkpoint Trends recorded a 10.38% return, while the Sensex declined by 0.88%. This divergence emphasises the stock’s relative strength and the market’s recognition of its business progress.



Price Stability and Trading Range


On the day of the all-time high, the stock exhibited price stability, opening and trading at Rs.105.32 without fluctuation. Such steadiness at a peak price level suggests a balanced demand-supply dynamic and a consolidation of gains. This behaviour often precedes further price discovery phases, reflecting investor confidence in the company’s valuation at these levels.




Checkpoint Trends or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Summary of Checkpoint Trends’ Market Journey


Checkpoint Trends’ ascent to its all-time high price of Rs.105.32 is the culmination of a sustained period of price appreciation and market recognition. The stock’s performance over the last decade, with returns exceeding 7000%, places it among the most remarkable performers in the Pharmaceuticals & Biotechnology sector. Its ability to maintain gains above key moving averages and outperform the Sensex and sector benchmarks across multiple time frames highlights a robust market presence.


While the stock’s recent gains have been substantial, the data reflects a consistent pattern of growth rather than isolated spikes. This consistency is supported by the company’s market capitalisation and sector positioning, which provide a foundation for continued market relevance.


Investors and market watchers may note the stock’s steady trading range at the new high, indicating a phase of price consolidation. Such phases often serve as important junctures in a stock’s price evolution, balancing demand and supply forces before the next directional move.



Checkpoint Trends in the Broader Market Context


Comparing Checkpoint Trends’ returns with the Sensex over various periods reveals a stark contrast. The stock’s 5-year return of 4601.79% far surpasses the Sensex’s 90.13%, while its 3-year return of 2443.96% eclipses the Sensex’s 34.98%. These figures underscore the stock’s exceptional growth trajectory relative to the broader market.


Such performance metrics are indicative of a company that has navigated its sector’s complexities effectively, delivering value to shareholders over the long term. The Pharmaceuticals & Biotechnology sector’s dynamic nature, combined with Checkpoint Trends’ market execution, has contributed to this outcome.



Conclusion


Checkpoint Trends’ achievement of a new all-time high at Rs.105.32 marks a significant milestone in its market history. The stock’s consistent gains over the past 21 days, strong outperformance against the Sensex and sector indices, and sustained trading above key moving averages collectively illustrate a robust market position. This milestone reflects the company’s enduring growth and price strength within the Pharmaceuticals & Biotechnology sector.



As the stock consolidates at this elevated level, its historical performance and current market dynamics provide a comprehensive picture of its journey to this peak. Checkpoint Trends stands as a noteworthy example of sustained value creation in India’s mid-cap pharmaceutical space.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News